SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wockhardt’s Chikalthana unit gets GMP certificate from UK MHRA

21 Dec 2016 Evaluate

UK health regulator -- UK Medicines and Healthcare Products Regulatory Agency (UK MHRA) has confirmed that Wockhardt’s manufacturing facility at Chikalthana in Maharashtra complies with good manufacturing practices (GMP).

Further, UK MHRA has considered the said manufacturing unit suitable for risk based inspection with reduced inspection frequency of two years from the existing inspection frequency of 1 year.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1916.45 29.60 (1.57%)
29-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1989.75
Dr. Reddys Labs. 1143.20
Cipla 1473.45
Lupin 2449.80
Zydus Lifesciences 1122.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: